{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:42:42Z","timestamp":1791412962674,"version":"4.3.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,12,18]],"date-time":"2014-12-18T00:00:00Z","timestamp":1418860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1245\/s10434-014-4285-2","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T09:36:02Z","timestamp":1418808962000},"page":"2416-2423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer"],"prefix":"10.1245","volume":"22","author":[{"given":"Amanda B.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fogelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly M.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Petzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Ngo-Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri","family":"Varadhachary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Aloia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H. G.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,18]]},"reference":[{"key":"4285_CR1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7326\/0003-4819-123-9-199511010-00014","volume":"123","author":"IH Rosenberg","year":"1995","unstructured":"Rosenberg IH, Roubenoff R. Stalking sarcopenia. Ann Intern Med. 1995;123:727\u20138.","journal-title":"Ann Intern Med."},{"key":"4285_CR2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s11605-012-1923-5","volume":"16","author":"P Peng","year":"2012","unstructured":"Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16:1478\u201386.","journal-title":"J Gastrointest Surg."},{"key":"4285_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpainsymman.2011.09.010","volume":"44","author":"S Dalal","year":"2012","unstructured":"Dalal S, Hui D, Bidaut L, et al. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Sympt Manag. 2012;44:181\u201391.","journal-title":"J Pain Sympt Manage."},{"key":"4285_CR4","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","volume":"15","author":"BH Tan","year":"2009","unstructured":"Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15:6973\u20139.","journal-title":"Clin Cancer Res."},{"key":"4285_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1017\/S0007114512001067","volume":"109","author":"KM Sebastiano Di","year":"2013","unstructured":"Di Sebastiano KM, Yang L, Zbuk K, et al. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr. 2013;109:302\u201312.","journal-title":"Br J Nutr."},{"key":"4285_CR6","first-page":"147","volume":"12","author":"C Jacquillat","year":"1986","unstructured":"Jacquillat C, Baillet F, Auclerc G, et al. Neoadjuvant chemotherapy of breast cancer. Drugs Exp Clin Res. 1986;12:147\u201352.","journal-title":"Drugs Exp Clin Res."},{"key":"4285_CR7","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/0277-5379(91)90442-G","volume":"27","author":"SM Scholl","year":"1991","unstructured":"Scholl SM, Asselain B, Palangie T, et al. Neoadjuvant chemotherapy in operable breast cancer. Eur J Cancer. 1991;27:1668\u201371.","journal-title":"Eur J Cancer."},{"key":"4285_CR8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF02234821","volume":"44","author":"VK Mehta","year":"2001","unstructured":"Mehta VK, Poen J, Ford J, et al. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis Colon Rectum. 2001;44:52\u20138.","journal-title":"Dis Colon Rectum."},{"key":"4285_CR9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1200\/JCO.2005.03.6095","volume":"24","author":"M Mohiuddin","year":"2006","unstructured":"Mohiuddin M, Winter K, Mitchell E, et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol. 2006;24:650\u20135.","journal-title":"J Clin Oncol."},{"key":"4285_CR10","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO;2-H","volume":"91","author":"E Ancona","year":"2001","unstructured":"Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001;91:2165\u201374.","journal-title":"Cancer."},{"key":"4285_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1442-2050.2002.00214.x","volume":"15","author":"TN Walsh","year":"2002","unstructured":"Walsh TN, Grennell M, Mansoor S, Kelly A. Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival. Dis Esophagus. 2002;15:121\u20134.","journal-title":"Dis Esophagus."},{"key":"4285_CR12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1634\/theoncologist.2012-0169","volume":"17","author":"E Fabbro Del","year":"2012","unstructured":"Del Fabbro E, Parsons H, Warneke CL, et al. The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist. 2012;17:1240\u20135.","journal-title":"Oncologist."},{"key":"4285_CR13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clnu.2011.08.008","volume":"31","author":"S Awad","year":"2012","unstructured":"Awad S, Tan BH, Cui H, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr (Edinburgh). 2012;31:74\u20137.","journal-title":"Clin Nutr (Edinburgh)."},{"key":"4285_CR14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jamcollsurg.2013.01.007","volume":"216","author":"W Clark","year":"2013","unstructured":"Clark W, Siegel EM, Chen YA, et al. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation. J Am Coll Surg. 2013;216:1070\u201381.","journal-title":"J Am Coll Surg."},{"key":"4285_CR15","unstructured":"Tempero MA, Malafa MP, Behrman SW, et al. Pancreatic adenocarcinoma, version 2.2014. J Natl Comp Cancer Netw. 2014;12:1083\u201393."},{"key":"4285_CR16","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1200\/JCO.2007.15.8642","volume":"26","author":"GR Varadhachary","year":"2008","unstructured":"Varadhachary GR, Wolff RA, Crane CH, et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008;26:3487\u201395.","journal-title":"J Clin Oncol."},{"key":"4285_CR17","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1200\/JCO.2007.15.8634","volume":"26","author":"DB Evans","year":"2008","unstructured":"Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008;26:3496\u2013502.","journal-title":"J Clin Oncol."},{"key":"4285_CR18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.gassur.2004.09.046","volume":"8","author":"JF Tseng","year":"2004","unstructured":"Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg. 2004;8:935\u201349; discussion 949\u201350.","journal-title":"J Gastrointest Surg."},{"key":"4285_CR19","first-page":"1299","volume-title":"Master of surgery","author":"DB Evans","year":"2007","unstructured":"Evans DB, Lee JE, Tamm EP, Pisters PWT. Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In: Fischer J, editor Master of surgery. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007:1299\u2013317.","edition":"5"},{"key":"4285_CR20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","volume":"33","author":"M Mourtzakis","year":"2008","unstructured":"Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997\u20131006.","journal-title":"Appl Physiol Nutr Metab."},{"key":"4285_CR21","first-page":"427","volume":"78","author":"CR Mehta","year":"1983","unstructured":"Mehta CR, Patel NR. A network algorithm for performing Fisher\u2019s exact test in r x c contingency tables. J Am Stat Assoc. 1983;78:427\u201334.","journal-title":"J Am Stat Assoc."},{"key":"4285_CR22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimator from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc."},{"key":"4285_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34:187\u2013220.","journal-title":"J R Stat Soc B."},{"key":"4285_CR24","first-page":"483","volume-title":"Classification and regression trees (CART) used for the exploration of prognostic factors measured on different scales","author":"B Lausen","year":"1994","unstructured":"Lausen B, Sauerbrei W, Schumacher V. Classification and regression trees (CART) used for the exploration of prognostic factors measured on different scales. Contr Stat. 1994:483\u201396."},{"key":"4285_CR25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ajcn\/80.2.271","volume":"80","author":"W Shen","year":"2004","unstructured":"Shen W, Punyanitya M, Wang Z, et al. Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr. 2004;80:271\u20138.","journal-title":"Am J Clin Nutr."},{"issue":"31","key":"4285_CR26","first-page":"763","volume":"2007","author":"W Shen","year":"2005","unstructured":"Shen W, Punyanitya M, Chen J, et al. Visceral adipose tissue: relationships between single slice areas at different locations and obesity-related health risks. Int J Obes (2005). 2007;31:763\u20139.","journal-title":"Int J Obes"},{"key":"4285_CR27","doi-asserted-by":"crossref","unstructured":"Fogelman DR, Holmes H, Mohammed K, et al. Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer? J Cachexia Sarcopenia Muscle. 2014;5:307\u201313.","DOI":"10.1007\/s13539-014-0145-y"},{"key":"4285_CR28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01635581.2014.894103","volume":"66","author":"M Barret","year":"2014","unstructured":"Barret M, Antoun S, Dalban C, et al. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer. 2014;66:583\u20139.","journal-title":"Nutr Cancer."},{"key":"4285_CR29","doi-asserted-by":"crossref","unstructured":"Wakabayashi H, Sakuma K. Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management. J Cachexia Sarcopenia Muscle. 2014.","DOI":"10.1007\/s13539-014-0162-x"},{"key":"4285_CR30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.physio.2013.08.008","volume":"100","author":"D Santa Mina","year":"2014","unstructured":"Santa Mina D, Clarke H, Ritvo P, et al. Effect of totalbody prehabilitation on postoperative outcomes: a systematic review and meta-analysis. Physiotherapy. 2014;100:196\u2013207.","journal-title":"Physiotherapy."},{"key":"4285_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13539-014-0138-x","volume":"5","author":"PL Campos-Ferraz de","year":"2014","unstructured":"de Campos-Ferraz PL, Andrade I, das Neves W, Hangai I, Alves CR, Lancha AH Jr. An overview of amines as nutritional supplements to counteract cancer cachexia. J Cachexia Sarcopenia Muscle. 2014;5:105\u201310.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4285_CR32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MCO.0000000000000032","volume":"17","author":"FG Girolamo Di","year":"2014","unstructured":"Di Girolamo FG, Situlin R, Mazzucco S, Valentini R, Toigo G, Biolo G. Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care. 2014;17:145\u201350.","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"4285_CR33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13539-014-0149-7","volume":"5","author":"JE Morley","year":"2014","unstructured":"Morley JE, von Haehling S, Anker SD. Are we closer to having drugs to treat muscle wasting disease? J Cachexia Sarcopenia Muscle. 2014;5:83\u20137.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4285_CR34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1470-2045(14)70155-X","volume":"15","author":"DS Hong","year":"2014","unstructured":"Hong DS, Hui D, Bruera E, et al. MABp1, a first-in-class true human antibody targeting interleukin-1alpha in refractory cancers: an open-label, phase 1 dose-escalation and expansion study. Lancet Oncol. 2014;15:656\u201366.","journal-title":"Lancet Oncol."},{"key":"4285_CR35","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-013-2886-9","volume":"20","author":"MH Katz","year":"2013","unstructured":"Katz MH, Marsh R, Herman JM, et al. Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol. 2013;20:2787\u201395.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-4285-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-4285-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T19:06:16Z","timestamp":1717614376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-4285-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,18]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["4285"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-4285-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,18]]}}}